Andrew J Mungall
Overview
Explore the profile of Andrew J Mungall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
18956
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Haile S, Corbett R, ONeill K, Xu J, Smailus D, Pandoh P, et al.
Front Genet
. 2024 Dec;
15:1466338.
PMID: 39687742
The advent of long-read (LR) sequencing technologies has provided a direct opportunity to determine the structure of transcripts with potential for end-to-end sequencing of full-length RNAs. LR methods that have...
2.
Porter V, Ng M, ONeill K, MacLennan S, Corbett R, Culibrk L, et al.
Genome Res
. 2024 Dec;
PMID: 39638560
Human papillomavirus (HPV) integration has been implicated in transforming HPV infection into cancer. To resolve genome dysregulation associated with HPV integration, we performed Oxford Nanopore long-read sequencing on 72 cervical...
3.
Takemon Y, Pleasance E, Gagliardi A, Hughes C, Csizmok V, Wee K, et al.
Genome Med
. 2024 Nov;
16(1):136.
PMID: 39578878
Background: Loss-of-function (LOF) alterations in tumour suppressor genes cannot be directly targeted. Approaches characterising gene function and vulnerabilities conferred by such mutations are required. Methods: Here, we computationally map genetic...
4.
Alduaij W, Jiang A, Villa D, Collinge B, Collinge B, Ben-Neriah S, et al.
Blood
. 2024 Oct;
145(6):590-596.
PMID: 39441916
High-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2), or "double-hit lymphoma," has been associated with a high risk of central nervous system (CNS) relapse. However, historic estimates are impacted...
5.
ONeill K, Pleasance E, Fan J, Akbari V, Chang G, Dixon K, et al.
Cell Genom
. 2024 Oct;
4(11):100674.
PMID: 39406235
The Long-Read Personalized OncoGenomics (POG) dataset comprises a cohort of 189 patient tumors and 41 matched normal samples sequenced using the Oxford Nanopore Technologies PromethION platform. This dataset from the...
6.
Collinge B, Ben-Neriah S, Hilton L, Alduaij W, Tucker T, Slack G, et al.
Blood
. 2024 Aug;
144(15):1611-1616.
PMID: 39133931
Fluorescence in situ hybridization (FISH) using break-apart probes is recommended for identifying high-grade B-cell lymphoma with MYC and BCL2 rearrangements (HGBCL-DH-BCL2). Unbalanced MYC break-apart patterns, in which the red or...
7.
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, et al.
Blood Cancer J
. 2024 Aug;
14(1):128.
PMID: 39112453
Follicular lymphoma (FL) exhibits considerable variability in biological features and clinical trajectories across patients. To dissect the diversity of FL, we utilized a Bernoulli mixture model to identify genetic subtypes...
8.
Kabeer F, Tran H, Andronescu M, Singh G, Lee H, Salehi S, et al.
Genome Biol
. 2024 Jul;
25(1):191.
PMID: 39026273
Background: The encoding of cell intrinsic drug resistance states in breast cancer reflects the contributions of genomic and non-genomic variations and requires accurate estimation of clonal fitness from co-measurement of...
9.
Widman A, Shah M, Frydendahl A, Halmos D, Khamnei C, Ogaard N, et al.
Nat Med
. 2024 Jun;
30(6):1655-1666.
PMID: 38877116
In solid tumor oncology, circulating tumor DNA (ctDNA) is poised to transform care through accurate assessment of minimal residual disease (MRD) and therapeutic response monitoring. To overcome the sparsity of...
10.
Deyell R, Shen Y, Titmuss E, Dixon K, Williamson L, Pleasance E, et al.
Nat Commun
. 2024 May;
15(1):4165.
PMID: 38755180
The role for routine whole genome and transcriptome analysis (WGTA) for poor prognosis pediatric cancers remains undetermined. Here, we characterize somatic mutations, structural rearrangements, copy number variants, gene expression, immuno-profiles...